Published in Ann Thorac Surg on November 01, 2010
The golden age of minimally invasive cardiothoracic surgery: current and future perspectives. Future Cardiol (2011) 1.32
Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: a propensity-matched comparison. J Thorac Cardiovasc Surg (2013) 1.13
A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery. J Thorac Cardiovasc Surg (2011) 1.11
Nonresectional single-suture leaflet remodeling for degenerative mitral regurgitation facilitates minimally invasive mitral valve repair. Ann Thorac Surg (2013) 0.93
Minimally invasive procedures - direct and video-assisted forms in the treatment of heart diseases. Arq Bras Cardiol (2014) 0.85
Anesthetic issues for robotic cardiac surgery. Ann Card Anaesth (2015) 0.83
Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis. J Zhejiang Univ Sci B (2014) 0.79
Minimally Invasive Cardiovascular Surgery: Incisions and Approaches. Methodist Debakey Cardiovasc J (2016) 0.75
Comparison of right anterolateral thorocotomy with standard median steronotomy for mitral valve replacement. Int Cardiovasc Res J (2013) 0.75
The role of age and comorbidities in postoperative outcome of mitral valve repair: A propensity-matched study. Medicine (Baltimore) (2016) 0.75
Anesthetic challenges in minimally invasive cardiac surgery: Are we moving in a right direction? Ann Card Anaesth (2016) 0.75
Is minimally invasive thoracoscopic surgery the new benchmark for treating mitral valve disease? Ann Cardiothorac Surg (2016) 0.75
Minimally invasive mitral valve repair through a right minithoracotomy approach. Ann Cardiothorac Surg (2015) 0.75
Propensity-matched analysis of minimally invasive mitral valve repair using a nationwide surgical database. Surg Today (2015) 0.75
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med (2008) 6.77
Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest (2005) 5.51
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Submarine canyons: hotspots of benthic biomass and productivity in the deep sea. Proc Biol Sci (2010) 3.98
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation (2007) 3.05
The renal papilla is a niche for adult kidney stem cells. J Clin Invest (2004) 3.03
Man and the last great wilderness: human impact on the deep sea. PLoS One (2011) 2.70
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol (2012) 2.56
Factors associated with primary graft failure after heart transplantation. Transplantation (2010) 2.38
World-wide whale worms? A new species of Osedax from the shallow north Atlantic. Proc Biol Sci (2005) 2.18
Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation (2012) 2.17
Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thorac Surg (2005) 2.15
Use of bicaval dual-lumen catheter for adult venovenous extracorporeal membrane oxygenation. Ann Thorac Surg (2011) 2.11
30-day readmissions after coronary artery bypass graft surgery in New York State. JACC Cardiovasc Interv (2011) 2.09
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv (2012) 2.08
Modified Bentall operation with a novel biologic valved conduit. Ann Thorac Surg (2010) 2.03
Proliferation and migration of label-retaining cells of the kidney papilla. J Am Soc Nephrol (2009) 1.99
Risk score for predicting long-term mortality after coronary artery bypass graft surgery. Circulation (2012) 1.83
Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation (2011) 1.79
Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Fail (2012) 1.79
Biotic and human vulnerability to projected changes in ocean biogeochemistry over the 21st century. PLoS Biol (2013) 1.78
Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation (2014) 1.76
The cost of medical management in advanced heart failure during the final two years of life. J Card Fail (2008) 1.71
Mechanisms of atrial tachyarrhythmias following surgical atrial fibrillation ablation. J Cardiovasc Electrophysiol (2006) 1.71
Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest (2008) 1.64
Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation (2006) 1.62
Long-term mortality of coronary artery bypass grafting and bare-metal stenting. Ann Thorac Surg (2011) 1.60
Effect of donor age on long-term survival following cardiac transplantation. J Card Surg (2006) 1.54
Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. Ann Thorac Surg (2013) 1.54
Use of carotid-subclavian arterial bypass and thoracic endovascular aortic repair to minimize cerebral ischemia in total aortic arch reconstruction. J Thorac Cardiovasc Surg (2010) 1.54
Preoperative assessment of high-risk candidates to predict survival after heart transplantation. Circ Heart Fail (2013) 1.53
Incidence and predictors of pacemaker placement after surgical ablation for atrial fibrillation. Ann Thorac Surg (2011) 1.52
A comparison of atrial arrhythmias after heart or double-lung transplantation at a single center: insights into the mechanism of post-operative atrial fibrillation. J Am Coll Cardiol (2009) 1.51
The New York risk score for in-hospital and 30-day mortality for coronary artery bypass graft surgery. Ann Thorac Surg (2012) 1.51
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Open distal anastomosis in aortic root replacement using axillary cannulation and moderate hypothermia. J Thorac Cardiovasc Surg (2009) 1.47
Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg (2007) 1.47
Laser energy source in surgical atrial fibrillation ablation: preclinical experience. Ann Thorac Surg (2006) 1.47
Long-term outcomes with a minimally invasive approach for resection of cardiac masses. Ann Thorac Surg (2010) 1.45
Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol (2006) 1.43
The relationship between perioperative temperature and adverse outcomes after off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2010) 1.42
Aortic valve replacement for patients with severe aortic stenosis: risk factors and their impact on 30-month mortality. Ann Thorac Surg (2009) 1.42
Totally endoscopic atrial septal defect repair with robotic assistance. Circulation (2003) 1.40
Staged percutaneous coronary intervention and minimally invasive valve surgery: results of a hybrid approach to concomitant coronary and valvular disease. J Thorac Cardiovasc Surg (2013) 1.38
Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation. J Invasive Cardiol (2016) 1.38
Coronary artery bypass grafting in patients with low ejection fraction. Circulation (2005) 1.36
Management of sternal wounds with bilateral pectoralis major myocutaneous advancement flaps in 114 consecutively treated patients: refinements in technique and outcomes analysis. Plast Reconstr Surg (2004) 1.33
Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg (2013) 1.33
Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis. Circ Heart Fail (2012) 1.32
The golden age of minimally invasive cardiothoracic surgery: current and future perspectives. Future Cardiol (2011) 1.32
Integrating economic evaluation methods into clinical and translational science award consortium comparative effectiveness educational goals. Acad Med (2011) 1.30
Robotic techniques improve quality of life in patients undergoing atrial septal defect repair. Ann Thorac Surg (2004) 1.29
Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant (2010) 1.28
High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest (2009) 1.22
Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg (2005) 1.22
Megafaunal communities in rapidly warming fjords along the West Antarctic Peninsula: hotspots of abundance and beta diversity. PLoS One (2013) 1.21
Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg (2003) 1.19
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg (2011) 1.17
Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg (2008) 1.16
Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg (2010) 1.16
Comparative composition, diversity and trophic ecology of sediment macrofauna at vents, seeps and organic falls. PLoS One (2012) 1.14
Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. J Thorac Cardiovasc Surg (2009) 1.14
Ligand tuning in asymmetric hydrovinylation of 1,3-dienes: a stereoselective route to either steroid-C20 (S) or -C20 (R) derivatives. J Am Chem Soc (2008) 1.13
Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transplant (2012) 1.13
Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg (2012) 1.12
Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. JACC Cardiovasc Interv (2013) 1.12